PDP-EA 是脂肪酸酰胺水解酶 (FAAH) 的激活剂，可增强 FAAH 的酰胺水解酶活性。

FaX-IN-1 对凝血因子Xa具有抑制作用，可用于研究血栓性静脉炎、动脉粥样硬化、脑栓塞、中风、肺栓塞。

MK-0941 is an orally active and allosteric glucokinase activator, has potential in the treatment of type 2 diabetes.

Pegnivacogin is a coagulation factor IXa RNA aptamer inhibitor.

DY268 是一种法尼样X 受体 (FXR)的拮抗剂(在 time-resolved FRET 分析中，IC50=7.5 nM)。在细胞分析中，它能够抑制 FXR 反式激活，IC50=468 nM。

Vonafexor (EYP001) 是一种法尼醇 X 受体激动剂，具有抗 HBV 作用。

Fexarine is a potent, selective agonist of farnesoid X receptor.

Tachioside has antiobesity, antioxidant and α-glucosidase inhibitory activities, it decreases lipid content in 3T3-L1 adipocytes by inhibiting lipogenesis, shows antiobesity activities. Tachioside can inhibit nitric oxide production in lipopolysaccharides-stimulated RAW 264.7 cells with IC50 value of 12.14 μM.

Tauro-Obeticholic acid 是一种牛磺酸的特性代谢物。Obeticholic Acid 是口服具有活性的法尼样 X 受体激动剂。